Modified nucleic acid and application thereof
A nucleic acid and chemical modification technology, applied in the modified nucleic acid and its application field, can solve the problems of RNA performance change and unclear application, and achieve the effect of reducing immune response, low immunogenicity and high immunogenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0158] DNA template preparation
[0159] 1) PCR method to prepare luciferase (Luc) and erythropoietin (EPO) DNA templates, and carry out in a 96-well PCR instrument.
[0160] PCR products include at least
[0161] A) a promoter sequence (any one of T7 promoter, T3 promoter or SP6 promoter);
[0162] B) a 5'UTR comprising at least one Kozak sequence;
[0163] C) 3'UTR;
[0164] D) Luc or EPO coding sequence;
[0165] E) polyA tail.
[0166] The specific sequences involved in the present invention are shown in Table 1.
[0167] Table 1
[0168]
[0169]
[0170] Amplify the DNA template according to the following reaction system:
[0171] The reaction volume is 50 μL (the reaction volume of a single tube, and multiple tubes are simultaneously reacted at one time), and the specific reaction system is shown in Table 2.
[0172] Table 2 Reaction system
[0173] component volume PrimeSTAR Max Premix (2×) 25μl PrimeSTAR Max DNA Polymerase 1μl ...
Embodiment 2
[0314] According to the single-type modified or multiple-type modified mRNA encoding EPO of the present invention, its immunogenicity is detected, and the evaluation standard is the modified mRNA immunoprecipitation test (RIP analysis) to detect Toll-like receptors TRL3, TRL7, TRL8 and RIG-1 and mRNA The level of binding; the specific steps are as follows:
[0315] cell transfection
[0316] About 24 hours after inoculation of 293T cells (purchased from the cell bank of the Chinese Academy of Sciences), the state of the cells in the 6-well plate was observed, and the confluence was 88% to 92%. In a biological safety cabinet, prepare 90% (volume percent) DMEM+10% (volume percent) FBS medium. 30 min before transfection, the medium in the well plate was discarded, and 1 ml of fresh medium was added to each well, namely 90% (volume percentage) DMEM+10% (volume percentage) FBS medium.
[0317] Preparation of transfection system: take 200μl opti-MEM, add 10μg test substance (conce...
Embodiment 3
[0330] According to the single-modified or multi-modified mRNA encoding EPO of the present invention, its immunogenicity is detected, and the evaluation standard is the level of TNFα and IL-8 in serum after intramuscular injection of the modified mRNA into mice.
[0331] 6-8-week-old balbc mice (purchased from Beijing Weitong Lihua Laboratory Animal Technology Co., Ltd.) were kept under SPF conditions and kept in ventilated cages under 12h light and 12h dark cycles. Various types of modified EPO mRNA were injected intramuscularly into balb / c mice, and the injection dose of each mouse was 100 μg. After 24 hours, the orbital blood was collected from the mice, and the serum was separated. Enzyme-linked immunosorbent assay (elisa) was performed with mouse IL-8 and TNFa kit (RayBio).
[0332] The result is as Figures 46 to 63 As shown, in mice, the immunogenicity of the mRNA synthesized by the modification strategy provided by the present invention is far less than that of the un...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com